A group of academics has accused Myriad Genetics, the US biotech company that holds patents over the BRCA1 and BRCA2 genetic tests for increased risk of breast cancer, of keeping secret clinical data obtained from the tests by saying the information is commercially sensitive...
The Academic Research Partnership (ARP) has bought a majority stake in the Glasgow Centre for Reproductive Medicine (GCRM), reportedly creating the UK's largest provider of NHS and private IVF services...
Over 1,000 people from 14 countries have had their genomes mapped by scientists. The researchers say their study will help them examine genetic variations at the scale of national populations and further identification of the rare genetic variations related to many diseases...
A man who donated his sperm to a lesbian couple 13 years ago in a private arrangement has been ordered to pay child support. He has called on the Government to make changes in the law so that private sperm donors are treated fairly....
A drug which prolongs life in a form of skin cancer associated with a genetic mutation has been recommended for use on the NHS...
The European Medicines Agency (EMA) has approved Glybera, a gene therapy to treat a rare genetic condition, lipoprotein lipase deficiency (LPLD), for sale across Europe. Glybera is the first gene therapy to be approved for the Western market and offers the first therapeutic treatment for people with LPLD....
Banked sperm-producing stem cells have been used to restore sperm production in monkeys made infertile by chemotherapy treatment...
This comprehensive handbook is written for psychologists and other health-care professionals and covers reproductive health across the lifespan. It will be of considerable value to both undergraduate and post-graduate students who are studying reproductive health...
Comment
Personalised medicine: a reality check
by Professor Donna Dickenson
The soaring promises made by personalised medicine advocates are probably loftier than in any other medical or scientific realm today. Francis Collins, former co-director of the Human Genome Project, wrote: 'We are on the leading edge of a true revolution in medicine, one that promises to transform the traditional "one size fits all" approach into a much more powerful strategy'...